Obstetrics & gynecology science

Korean Society of Obstetrics and Gynecology (대한산부인과학회)
권호 표지

Clinical Efficacy of HPV DNA Chip test in Human papillomavirus detection of Uterine Cervix

자궁경부의 인유두종 바이러스 검출에 있어 HPV DNA chip 검사의 임상적 유용성

Lee, Je-Hoon;Lee, Ki-Heon;Lee, In-Ho;Woo, Hyuk-Jun;Seong, Seok-Ju;Kim, Tae-Jin;Lim, Kyung-Taek;Shim, Jae-Uk;Park, Chong-Taik
이제훈;이기헌;이인호;우혁준;성석주;김태진;임경택;심재욱;박종택

  • Published : 20061000
⟨ Previous Next ⟩

Abstract

Objective: This study was performed to investigate the efficacy of HPV DNA chip method for detection and genotyping of various human papillomavirus in the patients with intraepithelial lesions of uterine cervix. Methods: The study subjects included two hundred patients with abnormal Pap smear from July 2004 to October 2004. After confirmed the pathological status of the cervix with colposcopic biopsy or conization, we evaluated for HPV infection and genotyping with the commercially available Hybrid-Capture II assay (HC-II) and HPV DNA chip. Then we compared the concordance rate between the two methods for the detection of HPV and analysed the HPV genotypes. Results: We compared the results in HPV DNA chip with those in HC-II. In result, the concordance rate between the two methods for the detection of HPV was 85.5% (171 of 200 cases). In 111 patients confirmed the presence of lesions higher than flat condyloma in cervix by pathologc examination, sensitivities of HC-II and HPV DNA chip in detecting HPV were 91.0% and 88.3%, respectively. In HPV DNA chip, HPV-16 was the most frequent type (14.7%) in all patients, the next frequent types were HPV-58 (14.1%) and HPV-18 (9.2%). Conclusion: We confirmed that HPV DNA chip method was as sensitive and effective method for detecting HPV in cervical lesions as HC-II. And that it would provide useful clinical information on genotyping and multiple infections of HPV.

목적: 비정상 자궁경부 세포검사 소견을 보인 환자 중 질확대경 검사나 원추절제술을 통해 조직학적 병변의 유무가 확인된 환자들을 대상으로 HC-II와 HPV DNA chip 검사를 시행하여 각 검사의 임상적 유용성을 확인하고자 한다. 연구 방법: 2004년 7월부터 10월까지 비정상 자궁경부 세포검사 결과로 본원 부인종양센터에서 질확대경하 조직검사 또는 원추절제술을 시행하여 조직학적 소견이 확인된 200명의 환자에서 HPV 감염을 확인하기 위해 HC-II와 HPV DNA chip 검사를 동시에 시행하여 HPV 검출에 두 검사방법의 일치율을 비교하고, HPV DNA chip의 결과로 확인된 HPV 아형들을 분석하였다. 결과: 200명의 대상 환자 중 HC-II와 HPV DNA chip의 결과가 일치한 경우는 171명 (85.5%) 이었다. 비정상 자궁경부세포검사를 보인 환자 중 조직 검사 상 편평콘딜로마 이상의 병변이 확인된 111명의 환자에서, HC-II와 HPV DNA chip 검사의 민감도는 각각 91.0%와 88.3%였다. HPV DNA chip 검사에서 검출된 HPV의 아형들은 HPV-16이 가장 흔하게 검출되었고 (14.7%), 그 다음으로 HPV-58과 HPV-18이 14.1%와 9.8%의 순으로 검출되었다. 결론: 자궁경부의 병변에서 HPV의 검출에 사용되는 HPV DAN chip 검사는 HC-II에 견줄만한 민감도를 갖는 효과적인 방법이다. 또한 HPV DNA chip은 감염된 HPV의 아형을 확인하고 중복감염 등 임상적으로 유용한 정보를 제공하는 장점을 가지고 있다.

Keywords

References

  1. 대한산부인과학회 부인종양위원회. 한국 부인암 등록사업 조사 보고서. 대한산부회지 2004; 47: 1029-70
  2. DeMay RM. Cytopathology of false negatives preceding cervical carcinomas. Am J Obstet Gynecol 1996; 175: 1110-3 https://doi.org/10.1016/S0002-9378(96)70013-3
  3. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities; a systematic review. Ann Intern Med 2000; 132: 810-9 https://doi.org/10.7326/0003-4819-132-10-200005160-00009
  4. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995; 141: 680-6 https://doi.org/10.1093/oxfordjournals.aje.a117485
  5. Lorincz AT. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimen: a tool for clinical management of equivocal Pap smears and for population screening. J Obstet Gynaecol Res 1996; 22: 629-36 https://doi.org/10.1111/j.1447-0756.1996.tb01081.x
  6. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J infect Dis 1994; 169: 235-40 https://doi.org/10.1093/infdis/169.2.235
  7. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol 1999; 189: 12-9 https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
  8. Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001; 357(9271): 1831-6 https://doi.org/10.1016/S0140-6736(00)04956-4
  9. Castle PE, Wacholder S, Sherman ME, Lorincz AT, Glass AG, Scott DR, et al. Absolute risk of a subsequent abnormal Pap among oncogenic human papillomavirus DNA-positive, cytologically negative women. Cancer 2002; 95(10): 2145-51 https://doi.org/10.1002/cncr.10927
  10. Rozendaal L, Walboomers JM, van der Linden JC, Voorhorst FJ, Kenemans P, Helmerhorst TJ, et al. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 1996; 68(6): 766-9 https://doi.org/10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z
  11. Ylitalo N, Sorensen P, Josefsson AM, Magnusson PK, Andersen PK, Ponten J, et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000; 355: 2194-8 https://doi.org/10.1016/S0140-6736(00)02402-8
  12. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324: 17-27 https://doi.org/10.1016/j.virol.2004.03.033
  13. Bernard H, Chan S, Manos MM, Ong C, Villa LL, Delius H, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplication, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms, J infect Dis 1994; 170: 1077-85 https://doi.org/10.1093/infdis/170.5.1077
  14. Lorincz A, Reid R, Jenson A, Greenberg M, Lancaster W, Kurman R. Human papillomavirus infection of the cervix. Relative risk association of 15 common anogenital types. Obstet Gynecol 1992; 79: 328-37 https://doi.org/10.1097/00006250-199203000-00002
  15. Munoz N, Bosch FX, De Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemioloic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-17 https://doi.org/10.1056/NEJMoa021641
  16. Cope JU, Hildesheim A, schiffman MH, Manos MM, Lorincz AT, Burk RD, et al. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol 1997; 35: 2262-5
  17. van Ham MAPC, Melchers WJG, Hanselaar AGJM, Bekkers RLM, Boonstra H, Massuger LFAG. Fluctuations in prevalence of cervical human papillomavirus in women frequently sampled during a single menstrual cycle. Br J Cancer 2002; 87: 373-6 https://doi.org/10.1038/sj.bjc.6600485
  18. Quint WGV, Scholte G, van Doorn LJ, Kleter B, Smits PHM, Lindeman J. Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF10 PCR and HPV genotyping. J Pathol 2001; 194: 51-8 https://doi.org/10.1002/path.855
  19. Kim CJ, Jeong JK, Park MS, Park TS, Park TC, Namkoong SE, et al. HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions. Gynecol Oncol 2003; 89: 210-7 https://doi.org/10.1016/S0090-8258(02)00069-0
  20. Lee GY, Kim SM, Rim SY, Choi HS, Park CS, Nam JH. Human papillomavirus (HPV) genotyping by HPV DNA Chip in cervical cancer and precancerous lesions. Int J Gynecol Cancer 2005; 15(1): 81-7
  21. Bosch F, Manos M, Munoz N, Sherman M, Jansen A, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802 https://doi.org/10.1093/jnci/87.11.796
  22. Wheeler C, Parmenter C, Hunt W, Becker T, Greer C, Hilesheim A, et al. Determination of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm Dis 1993; 20: 286-9 https://doi.org/10.1097/00007435-199309000-00009
  23. Hwang HS, Park MS, Lee SY, Kwon KH, Pang MG. Distribution and prevalence of human papillomavirus genotypes in routine Pap smear of 2,470 Korean women determined by DNA chip. Cancer Epidemiol Biomarkers Prev 2004; 13(12): 2153-6
  24. 김판영, 이동운, 서정호, 선우재근, 배동한, 정동준. 자궁경부 종양에서 인유두종 바이러스 아형에 관한 연구. 대한산부회지 2003; 46: 2005-12